Payman Khales Assumes Role as Integer President and CEO

(NYSE:ITGR), ~ Planned Leadership Transition Completed ~ PLANO, Texas, Oct. 24, 2025 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today shared that, as part of a planned transition originally announced in April 2025, Payman Khales has assumed the role of President and Chief […]

Hanmi Financial Declares Cash Dividend of $0.27 per share

(NASDAQ:HAFC), LOS ANGELES, Oct. 24, 2025 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced that its Board of Directors declared a cash dividend on its common stock for the 2025 fourth quarter of $0.27 per share. The dividend will be paid on November

Gentex Reports Third Quarter 2025 Financial Results

(NASDAQ:GNTX), ZEELAND, Mich., Oct. 24, 2025 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, dimmable glass, fire protection technologies, medical devices, and consumer electronics, today reported financial results for the three and nine months ended September 30, 2025. Third Quarter 2025 Highlights Gentex and VOXX International Corporation (“VOXX”)

DOW INVESTOR DEADLINE TUESDAY: Dow Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD

(NYSE:DOW), SAN DIEGO, Oct. 24, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23, 2025, all dates inclusive (the “Class Period”), have until this Tuesday, October 28, 2025 to seek appointment as lead plaintiff of the

Tidal Financial Group and FundVantage Trust Announce Strategic Partnership to Deliver End-to-End ETF Solutions for Advisors

MILWAUKEE, Wis., Oct. 24, 2025 (GLOBE NEWSWIRE) — Tidal Financial Group, a leading ETF and fund services platform, and FundVantage Trust, a multi-series trust supporting advisors across ETFs, mutual funds, and private market strategies, today announced a strategic partnership to simplify and accelerate ETF creation for investment advisors. With ETFs projected to grow in the

From the Pentagon to Main Street: The Hidden Fortune Beneath America’s Feet

Washington, D.C., Oct. 24, 2025 (GLOBE NEWSWIRE) — The Pentagon's Defense Logistics Agency has begun an aggressive campaign to secure critical minerals vital to jet fighters, satellites, and A.I. systems–part of what insiders describe as a broader Trump-era strategy to reclaim U.S. resource independence. But former CIA and Pentagon advisor Jim Rickards says the military's

HealthLynked Launches New MedOfficeDirect Shopify Platform at DiscountOnlineMedicalSupplies.com with Improved Performance and Lower Prices

(Other OTC:HLYK),(OTC US:HLYK), NAPLES, Fla., Oct. 24, 2025 (GLOBE NEWSWIRE) — via IBN — HealthLynked Corp. (OTCQB: HLYK), a leading provider of healthcare technology and patient engagement solutions, today announced the launch of its new MedOfficeDirect e-commerce platform built on Shopify, now operating under the URL DiscountOnlineMedicalSupplies.com. The upgraded platform introduces faster performance, enhanced security,

Baker Hughes, Aramco to Expand Integrated Coiled Tubing Drilling Operations Across Saudi Arabia

(NASDAQ:BKR), Multi-year agreement will increase Baker Hughes' coiled tubing drilling fleet from four to 10 units across the country's natural gas fields Additional scope includes underbalanced drilling services, operational management, well construction and geosciences HOUSTON and LONDON, Oct. 24, 2025 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR), an energy technology company, announced Friday an award

Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025

(NASDAQ:SYRE), WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases, today announced scientific presentations at the ACR Convergence Congress. “We are excited to share follow-up data out

Orna Therapeutics Announces Encore Presentation at the American College of Rheumatology Annual Meeting Supporting its in vivo CAR Therapy Approach in Autoimmune Diseases

Orna Therapeutics, a leading biotechnology company developing a proprietary pipeline ofin vivotherapies across a broad range of autoimmune and oncology indications, today announced an upcoming presentation at the American College of Rheumatology (ACR) Annual Meeting being held October 24-29, 2025, in Chicago, Illinois. This dataset is a broader update on Orna's lead program, ORN-252, as

Scroll to Top